Boehringer Scores 2nd Bellwether Win In Conn. Pradaxa Suit
A Connecticut state jury on Monday sided with Boehringer Ingelheim Pharmaceuticals Inc. in a second bellwether trial as part of a consolidated state proceeding over the alleged bleeding risk of its...To view the full article, register now.
Already a subscriber? Click here to view full article